Evidence map›Paper›PMID 39669626›Full record

ArticleGenetics in medicine open2024

Variant reclassification and recontact research: A scoping review.

Abhinav Thummala, Rhea Sudhakaran, Anoop Gurram, Jacqueline Mersch, Alexa Badalamenti, Garrett Gottaway, Jason Y Park, Jeffrey A Sorelle, Sukh Makhnoon

Abstract readScoping Review
In one paragraph

Article in Genetics in medicine open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Not Forgotten: Patient Experiences with Genetic Variant Reclassifications.medRxiv : the preprint server for health sciences · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abhinav ThummalaMedical School, University of Texas Southwestern Medical Center, Dallas, TX.
Rhea SudhakaranMedical School, University of Texas Southwestern Medical Center, Dallas, TX.
Anoop GurramMedical School, University of Texas Southwestern Medical Center, Dallas, TX.
Jacqueline MerschClinical Cancer Genetics, University of Texas Southwestern Medical Center, Dallas, TX.
Alexa BadalamentiClinical Cancer Genetics, University of Texas Southwestern Medical Center, Dallas, TX.
Garrett GottawayDivision of Pediatrics, Genetics and Metabolism, University of Texas Southwestern Medical Center, Dallas, TX.
Jason Y ParkDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX.
Jeffrey A SorelleDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX.
Sukh MakhnoonPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX.

Funding

Multilevel investigation of uncertain and reclassified genomic variants in clinical oncologyR00CA256216 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MAKHNOON, SUKH · 2022 to 2024
$693k
NCI NIH HHS R00 CA256216
6 · The paper itself

Abstract

Purpose: A primary challenge in clinical genetics is accurate interpretation of identified variants and relaying the information to patients and providers. Inconsistencies around handling variant reclassifications and notifying patients, combined with the lack of prescriptive guidelines on re-evaluation, reanalysis, and return of variants, has created practice challenges. Although relevant empirical work has emerged, the scope and outcomes of this research have not been characterized. Methods: We conducted a systematic literature review of variant reclassification and recontact research (2013-2023) across subdisciplines of medical genetics. Of the 159 nonduplicate records screened, we summarize findings from 54 included research articles describing variant reclassification frequencies, outcomes, and stakeholder perspectives on recontact. Results: The included articles reported on active reclassification ( Conclusion: Many active reclassification studies reapplied standard variant classification guideline to previously reported variants-thus demonstrating the number of variants that would be successfully reclassified if reinterpretation and reanalysis were performed routinely. Research gaps identified include the need for understanding practices and opinions of nongenetics providers and engaging in deliberative democracy exercises to reach consensus on these issues.

Indexed as

Genetic testingRecontactVariant reclassification

Identifiers

PMID39669626
PMCPMC11613892

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.